ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
港股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
派格生物医药-B
10.200
-0.640
-5.90%
手动刷新
成交量:
79.96万
成交额:
826.24万
市值:
39.37亿
市盈率:
-12.14
高:
10.840
开:
10.840
低:
10.000
收:
10.840
数据加载中...
总览
公司
新闻
公告
公司资料
公司名字:
派格生物医药-B
交易所:
SEHK
成立时间:
2008
员工人数:
53
公司地址:
Room 606,Building 1,Haozhang Tower,Gongshu District,Hangzhou,Zhejiang Province,China
官网:
http://www.pegbio.com
邮编:
215123
电话:
86 512 6295 6128
传真:
86 512 6295 6130
简介:
派格生物医药(苏州)有限公司是一家专注于创新药物开发的生物医药公司,2008年5月成立于苏州工业园区生物产业园(bioBay)。基于对慢病发病机制、慢病患者治疗需求以及慢病市场竞争的深刻理解,公司聚焦新作用机制、具有潜在优势的靶点,通过HECTORTM核心技术体系自主开发成药性高、疗效和安全性良好的药物分子,广泛覆盖2型糖尿病、非酒精性脂肪肝病、肥胖、高尿酸血症及痛风以及阿尔兹海默症等患者数量大、用药周期长的多种慢性疾病,并逐渐延伸到其他慢病领域,包括阿片类药物引起的便秘、先天性高胰岛素血症等。
董事
名称
职位
Michael MIN XU
董事长,执行董事,战略发展委员会主席,提名委员会委员
王小军
执行董事,薪酬与考核委员会委员
ZHANG JIANCUN
独立非执行董事,薪酬与考核委员会主席,提名委员会主席
陈秧秧
独立非执行董事,审计委员会委员
范新鹏
独立非执行董事,薪酬与考核委员会委员,提名委员会委员,审计委员会主席
ZHOU Xiangjun
非执行董事,战略发展委员会委员,审计委员会委员
徐宇虹
非执行董事,战略发展委员会委员
翟婷
非执行董事
李宏凯
非执行董事
王梦娇
监事会主席,职工代表监事
孔勇军
监事
李东
监事
股东
名称
职位
Michael MIN XU
总经理
王小军
财务总监
黄一峰
董事会秘书,联席公司秘书,董事会助理
陈婉梅
联席公司秘书
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02565/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02565","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","market":"HK","secType":"STK","nameCN":"派格生物医药-B","latestPrice":10.2,"timestamp":1748592503030,"preClose":10.84,"halted":0,"volume":799600,"delay":0,"floatShares":279164339,"shares":385955532,"eps":-0.8404179448460801,"marketStatus":"休市中","change":-0.64,"latestTime":"05-30 16:08:23","open":10.84,"high":10.84,"low":10,"amount":8262390,"amplitude":0.077491,"askPrice":10.24,"askSize":12000,"bidPrice":10.2,"bidSize":21500,"shortable":0,"etf":0,"ttmEps":-0.8404179448460801,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1748827800000},"marketStatusCode":7,"adr":0,"listingDate":1748275200000,"exchange":"SEHK","adjPreClose":10.84,"openAndCloseTimeList":[[1748568600000,1748577600000],[1748581200000,1748592000000]],"volumeRatio":0.15349667577010448,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","floatShares":279164339,"roa":"-61.30%","roe":"-224.15%","lyrEps":-0.840418,"volumeRatio":0.15349667577010448,"shares":385955532,"dividePrice":0,"high":10.84,"amplitude":0.077491,"preClose":10.84,"low":10,"week52Low":10,"pbRate":"69.31","week52High":13.5,"institutionHeld":0,"latestPrice":10.2,"committee":0.283582,"eps":-0.8404179448460801,"divideRate":0,"volume":799600,"delay":0,"ttmEps":-0.8404179448460801,"open":10.84,"prevYearClose":15.6,"prevWeekClose":15.6,"prevMonthClose":15.6,"prevQuarterClose":15.6,"fiveDayClose":15.6,"twentyDayClose":15.6,"sixtyDayClose":15.6},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":61902235,"yearFounded":2008,"employeeNum":53,"address":"Room 606,Building 1,Haozhang Tower,Gongshu District,Hangzhou,Zhejiang Province,China","zipCode":"215123","officePhone":"86 512 6295 6128","officeFax":"86 512 6295 6130"},"stockCompanyDetail":{"websiteUrl":"http://www.pegbio.com","stockEarnings":[{"period":"1week","weight":-0.3462},{"period":"ytd","weight":-0.3462}],"compareEarnings":[{"period":"1week","weight":-0.0132},{"period":"1month","weight":0.0529},{"period":"3month","weight":0.0152},{"period":"6month","weight":0.199},{"period":"1year","weight":0.2775},{"period":"ytd","weight":0.161}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"派格生物医药(苏州)有限公司是一家专注于创新药物开发的生物医药公司,2008年5月成立于苏州工业园区生物产业园(bioBay)。基于对慢病发病机制、慢病患者治疗需求以及慢病市场竞争的深刻理解,公司聚焦新作用机制、具有潜在优势的靶点,通过HECTORTM核心技术体系自主开发成药性高、疗效和安全性良好的药物分子,广泛覆盖2型糖尿病、非酒精性脂肪肝病、肥胖、高尿酸血症及痛风以及阿尔兹海默症等患者数量大、用药周期长的多种慢性疾病,并逐渐延伸到其他慢病领域,包括阿片类药物引起的便秘、先天性高胰岛素血症等。","exchange":"SEHK","name":"派格生物医药-B","nameEN":"PEGBIO CO-B"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"02565\",market:\"HK\",,,undefined,":{"directors":[{"name":"Michael MIN XU","position":"董事长,执行董事,战略发展委员会主席,提名委员会委员"},{"name":"王小军","position":"执行董事,薪酬与考核委员会委员"},{"name":"ZHANG JIANCUN","position":"独立非执行董事,薪酬与考核委员会主席,提名委员会主席"},{"name":"陈秧秧","position":"独立非执行董事,审计委员会委员"},{"name":"范新鹏","position":"独立非执行董事,薪酬与考核委员会委员,提名委员会委员,审计委员会主席"},{"name":"ZHOU Xiangjun","position":"非执行董事,战略发展委员会委员,审计委员会委员"},{"name":"徐宇虹","position":"非执行董事,战略发展委员会委员"},{"name":"翟婷","position":"非执行董事"},{"name":"李宏凯","position":"非执行董事"},{"name":"王梦娇","position":"监事会主席,职工代表监事"},{"name":"孔勇军","position":"监事"},{"name":"李东","position":"监事"}],"executives":[{"name":"Michael MIN XU","position":"总经理"},{"name":"王小军","position":"财务总监"},{"name":"黄一峰","position":"董事会秘书,联席公司秘书,董事会助理"},{"name":"陈婉梅","position":"联席公司秘书"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02565\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02565\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02565\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02565\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02565","date":"2025-05-30","current":-12.743079,"percent":1,"low":-19.497942,"twenty":-15.470266,"median":-13.542645,"eighty":-13.135794,"high":-12.743079,"avg":-14.696197,"sd":2.46554,"marketCap":3936746426},"quantilePoints":[{"date":"2025-05-30","current":-12.743079,"twenty":-15.470266,"median":-13.542645,"eighty":-13.135794,"marketCap":3936746426}],"updateTime":1748660419452}}}